Chief Commercial Officer · SOLENO THERAPEUTICS INC · Common Stock
Side
A
Value
—
Shares
28.6K
Price
—
Executed
Jan 21, 2026
Disclosed
Jan 23, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 21 executedJan 23, 2026 disclosed
SLNO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 65.9% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Manning Meredith filed this Form 4 reporting a grant or award of SLNO on Jan 21, 2026. It became public on Jan 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Manning Meredithcik:0001752631
Issuer
SOLENO THERAPEUTICS INCcik:0001484565
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for SLNO is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
